BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu Y, Xing L, Li L, Wu J, He J, Huang Y. Coordination of rigidity modulation and targeting ligand modification on orally-delivered nanoparticles for the treatment of liver fibrosis. J Control Release 2021;341:215-26. [PMID: 34822908 DOI: 10.1016/j.jconrel.2021.11.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Vu TQ, Sant'Anna LE, Kamat NP. Tuning Targeted Liposome Avidity to Cells via Lipid Phase Separation. Biomacromolecules 2023. [PMID: 36943688 DOI: 10.1021/acs.biomac.2c01338] [Reference Citation Analysis]
2 Yu Y, Li S, Yao Y, Shen X, Li L, Huang Y. Increasing stiffness promotes pulmonary retention of ligand-directed dexamethasone-loaded nanoparticle for enhanced acute lung inflammation therapy. Bioactive Materials 2023;20:539-547. [DOI: 10.1016/j.bioactmat.2022.06.016] [Reference Citation Analysis]
3 Zhang Y, Wang Y, Li X, Nie D, Liu C, Gan Y. Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications. J Control Release 2022;352:813-32. [PMID: 36368493 DOI: 10.1016/j.jconrel.2022.11.010] [Reference Citation Analysis]
4 Khalili L, Dehghan G, Sheibani N, Khataee A. Smart active-targeting of lipid-polymer hybrid nanoparticles for therapeutic applications: Recent advances and challenges. Int J Biol Macromol 2022;213:166-94. [PMID: 35644315 DOI: 10.1016/j.ijbiomac.2022.05.156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li M, Gao Z, Cui J. Modulation of Colloidal Particle Stiffness for the Exploration of Bio-Nano Interactions. Langmuir 2022. [PMID: 35617605 DOI: 10.1021/acs.langmuir.2c01117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]